

Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results and issuing FY26 revenue guidance above estimates.
You can purchase shares of BeyondSpring (NASDAQ:BYSI) through any online brokerage.
Other companies in BeyondSpring’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
There is no analysis for BeyondSpring to provide a consensus price target.
The stock price for BeyondSpring (NASDAQ: BYSI) is $0.5991 last updated October 30, 2026 at 6:28 PM EDT.
There are no upcoming dividends for BeyondSpring.
BeyondSpring does not have any upcoming earnings scheduled.
There is no upcoming split for BeyondSpring.
BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin...